Industry Analysis
The crystal growth breakthrough targets the most lethal gap between perovskite lab samples and wafer-scale manufacturing. Five years of stagnation on defect density and interface recombination could end if grain size shifts from sub-micron to micron scale—multiplying carrier lifetime tenfold and resetting tandem efficiency ceilings.
Ripple effects propagate upstream: PVD/CVD deposition windows face recalibration, forcing AMAT and Lam to re-engineer recipes. Precursor purity jumps toward 99.999%, positioning Merck and Sumitomo Chemical as early winners.
Compliance risk is acute. Lead-based precursors face unresolved EU REACH costs; lead-free alternatives still fail 2,000-hour damp-heat aging. Methylamine supply concentrates in Taiwan, China and a few Japanese suppliers—disruption scenarios must enter BOM models.
Competitively, LONGi and Tongwei will launch tandem pilot lines within 12 months to secure patent windows. Oxford PV accelerates CIGS integration with First Solar. Naura, shipping a dedicated ALD module first, captures the domestic-substitution head start.
The defining variable over 18 months is not efficiency but the GW-scale yield ramp. Whoever crosses 85% yield first owns pricing power.
This page displays AI-generated summaries and metadata for research purposes. Original content belongs to the respective publishers.